Current clinical practice of electroconvulsive therapy and repetitive transcranial magnetic stimulation in psychiatry, a German sample.


Journal

European archives of psychiatry and clinical neuroscience
ISSN: 1433-8491
Titre abrégé: Eur Arch Psychiatry Clin Neurosci
Pays: Germany
ID NLM: 9103030

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 12 08 2019
accepted: 13 01 2020
pubmed: 31 1 2020
medline: 14 1 2022
entrez: 31 1 2020
Statut: ppublish

Résumé

The purpose of the study was to evaluate the current clinical practice of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation in German psychiatry. Case-based data (> 1.000.000 cases) were collected according to §21 of the German hospital remuneration law from January 2015 to December 2017. The study cohort comprises approximately 35-40% of the annual psychiatric cases and hospitals in Germany. Frequency of ECT and rTMS cases were investigated considering main diagnoses according to ICD-10 and treatment settings (inpatient vs. day-care). ECT cases with short-term hospitalization (≤ 4 days) were supposed to be maintenance ECT cases. A linear regression analysis was conducted to estimate trends in the use of ECT and rTMS. Different groups were compared using Chi-square tests. ECT and rTMS cases appear to increase in total during the observation period possibly due to facilities newly introducing ECT and rTMS but also to increased frequency of treatments. Both treatments were rarely performed in day-care settings (0.89% and 11.25%). ECT was performed in 1.72% of all cases with affective disorders and in 1.48% with major depressions, respectively. Age ≥ 65 years, females, severe and psychotic depression were significantly associated with a higher rate of ECT cases. > 40% of all ECT cases were possibly maintenance ECT cases. Only 0.60% of these were performed in day- care settings. rTMS was primarily performed in major depression (86,7% of all rTMS cases). This study suggests a growing demand for ECT and rTMS. Nevertheless, the use of ECT is still low compared to the high prevalence of treatment resistant depression. The use of rTMS is even lower and seems to be restricted to specialized institutions. Maintenance ECT is frequently carried out in an inpatient setting. Limitations of this study are the case- and group-based analysis, missing data on outpatient services and treatment sessions per case. Therefore, the database is not necessarily representative for the entire German healthcare system. Further studies are needed to verify the presented findings and should address the feasibility of ambulatory and day-care ECT services.

Identifiants

pubmed: 31996994
doi: 10.1007/s00406-020-01099-x
pii: 10.1007/s00406-020-01099-x
pmc: PMC8179911
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

181-190

Commentaires et corrections

Type : ErratumIn

Références

Psychol Med. 2001 Jul;31(5):929-34
pubmed: 11459391
Int J Neuropsychopharmacol. 2006 Dec;9(6):641-54
pubmed: 16939662
J Clin Psychiatry. 2015 Oct;76(10):1374-84
pubmed: 26528644
Nervenarzt. 1998 Jan;69(1):15-26
pubmed: 9522329
Am J Psychiatry. 1998 Jan;155(1):22-9
pubmed: 9433334
Clin Neurophysiol. 2017 Jan;128(1):56-92
pubmed: 27866120
CNS Spectr. 2012 Mar;17(1):24-30
pubmed: 22790115
Biol Psychiatry. 2013 Jan 15;73(2):119-26
pubmed: 23059049
Am J Psychiatry. 2015 Jan;172(1):52-8
pubmed: 25157964
JAMA Psychiatry. 2017 Feb 1;74(2):143-152
pubmed: 28030740
Arch Gen Psychiatry. 2002 Jul;59(7):605-11
pubmed: 12090813
J Clin Psychiatry. 2011 Dec;72(12):1660-8
pubmed: 22244025
Am J Psychiatry. 1996 Oct;153(10):1288-92
pubmed: 8831436
Biol Psychiatry. 2007 Dec 1;62(11):1208-16
pubmed: 17573044
Psychiatr Serv. 1997 Dec;48(12):1537-42
pubmed: 9406260
J Clin Psychiatry. 1998 Jan;59(1):8-13
pubmed: 9491059
Psychoneuroendocrinology. 2008 Jul;33(6):821-31
pubmed: 18468810
J ECT. 1999 Dec;15(4):245-51
pubmed: 10614030
Clin Neurophysiol. 2017 Oct;128(10):1961-1970
pubmed: 28829979
World J Biol Psychiatry. 2013 Aug;14(6):432-40
pubmed: 22409536
Convuls Ther. 1987;3(3):204-209
pubmed: 11940917
J Affect Disord. 2017 Jan 15;208:284-290
pubmed: 27794252
J ECT. 2012 Mar;28(1):39-47
pubmed: 22330700
Psychiatry Res. 2018 Apr;262:407-412
pubmed: 28923432
Neuropsychiatry (London). 2014 Feb;4(1):33-54
pubmed: 24778709
Clin Neurophysiol. 2017 May;128(5):716-724
pubmed: 28315614
Clin Neurophysiol. 2009 Dec;120(12):2008-2039
pubmed: 19833552
Nervenarzt. 2005 May;76(5):597-612
pubmed: 15448918
Lancet. 2003 Mar 8;361(9360):799-808
pubmed: 12642045
Clin Neurophysiol. 2014 Nov;125(11):2150-2206
pubmed: 25034472
J Forensic Sci. 2000 Nov;45(6):1197-202
pubmed: 11110170
Am J Geriatr Psychiatry. 2019 May;27(5):548-558
pubmed: 30527274
J Psychiatr Pract. 2012 Mar;18(2):130-6
pubmed: 22418405
Br J Psychiatry. 2015 Jan;206(1):67-71
pubmed: 25323140
J Physiol. 2000 Sep 15;527 Pt 3:633-9
pubmed: 10990547
Convuls Ther. 1992;8(1):12-18
pubmed: 11941144
Am J Psychiatry. 1995 Jun;152(6):869-75
pubmed: 7755116
Depress Anxiety. 2016 Aug;33(8):746-53
pubmed: 27059158
Am J Geriatr Psychiatry. 2015 Mar;23(3):274-82
pubmed: 24951182
Brain Behav. 2012 May;2(3):283-344
pubmed: 22741102
Neuropsychopharmacology. 2018 Oct;43(11):2231-2238
pubmed: 29946106
Psychiatr Serv. 2009 Nov;60(11):1439-45
pubmed: 19880458
Depress Anxiety. 2013 Jul;30(7):614-23
pubmed: 23349112
Convuls Ther. 1997 Dec;13(4):242-52
pubmed: 9437568
Encephale. 2017 Feb;43(1):3-9
pubmed: 28034451
Neuropsychol Rehabil. 2011 Oct;21(5):602-17
pubmed: 21819181
Am J Psychiatry. 2006 Nov;163(11):1905-17
pubmed: 17074942
Psychol Med. 2014 Jan;44(2):225-39
pubmed: 23507264
J ECT. 2016 Dec;32(4):236-242
pubmed: 27227401
World Psychiatry. 2016 Feb;15(1):85-6
pubmed: 26833619
J Clin Psychiatry. 2000 Jul;61(7):534-9; quiz 540
pubmed: 10937616
Neurosci Biobehav Rev. 2018 Sep;92:291-303
pubmed: 29763711
Neurology. 2001 Nov 27;57(10):1899-901
pubmed: 11723286
Fortschr Neurol Psychiatr. 2016 Oct;84(S 02):S63-S66
pubmed: 27806415
JAMA Psychiatry. 2017 Aug 1;74(8):798-804
pubmed: 28658489
World J Psychiatry. 2015 Jun 22;5(2):170-81
pubmed: 26110119
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 3;51:181-9
pubmed: 24556538
JAMA Psychiatry. 2017 Aug 1;74(8):779-780
pubmed: 28658461
Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S86-90
pubmed: 11748792

Auteurs

Charles Timäus (C)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, University of Göttingen, Von-Siebold-Str. 5, 37075, Göttingen, Germany. charles.timaeus@med.uni-goettingen.de.

Jonathan Vogelgsang (J)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, University of Göttingen, Von-Siebold-Str. 5, 37075, Göttingen, Germany.

Bernhard Kis (B)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, University of Göttingen, Von-Siebold-Str. 5, 37075, Göttingen, Germany.
Department of Psychiatry, Psychotherapy and Psychosomatics, St. Elisabeth Hospital Niederwenigern, Contilia Group, Essener Straße 31, 45529 Hattingen, Germany.

Katrin Radenbach (K)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, University of Göttingen, Von-Siebold-Str. 5, 37075, Göttingen, Germany.

Claus Wolff-Menzler (C)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, University of Göttingen, Von-Siebold-Str. 5, 37075, Göttingen, Germany.

Kiriaki Mavridou (K)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, University of Göttingen, Von-Siebold-Str. 5, 37075, Göttingen, Germany.

Stephan Gyßer (S)

Division of Software Development and Business Intelligence, GSG Consulting GmbH, Flughafenring 2, 44319, Dortmund, Germany.

Philipp Hessmann (P)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, University of Göttingen, Von-Siebold-Str. 5, 37075, Göttingen, Germany.

Jens Wiltfang (J)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, University of Göttingen, Von-Siebold-Str. 5, 37075, Göttingen, Germany.
German Center for Neurodegenerative Diseases (DZNE), Von-Siebold-Str. 3a, 37075, Göttingen, Germany.
iBiMED, Medical Science Department, University of Aveiro, Aveiro, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH